July 15, 2024
Transfection Reagents And Equipment Market

DNA and RNA transfection reagents is fastest growing segment fueling the growth of Transfection Reagents And Equipment Market

The global Transfection Reagents And Equipment Market is estimated to be valued at US$ 1,165.6 Mn in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Transfection reagents and equipment are used to transfer genetic material into cells. Transfection technologies are widely used in research and therapeutics development for various purposes such as overexpression or gene silencing studies.

Market key trends:
DNA and RNA transfection is gaining traction due to its advantages for various applications in cell biology research and therapeutics development. The rising preference for non-viral gene transfer methods over viral vectors is fueling the demand for transfection reagents. Furthermore, growth in biopharmaceutical industry and increasing R&D investments in cell-based research are some of the factors expected to propel the growth of transfection reagents and equipment market during the forecast period.

Segment Analysis

The global transfection reagents and equipment market is segmented into transfection reagents and equipment. Among these, the transfection reagents segment dominated the market in 2021 and accounted for the largest revenue share. This is attributed to the wide applications of transfection reagents in gene expression, knockdown experiments, protein production, and epigenetics. Transfection reagents are used in various core facilities like high throughput screening centers, sequencing centers, imaging facilities, proteomics facilities, and genomic analysis centers. The equipment segment is expected to witness faster growth during the forecast period due to technological advancements in transfection equipment.

Key Takeaways
The global Transfection Reagents And Equipment Market Demand is expected to witness high growth, exhibiting CAGR of 9.3% over the forecast period, due to increasing R&D investments in life science research and biomedicine.

The regional analysis showed that North America dominated the global transfection reagents and equipment market in 2021 and is expected to maintain its leading position over the forecast period. This is attributed to the presence of major players and advanced research infrastructure in the region. Asia Pacific is projected to witness the fastest growth during the forecast period owing to increasing government funding for life science research in emerging countries.

Key players operating in the transfection reagents and equipment market are Qiagen NV, Promega Corporation, Polyplus-transfection SA, Mirus Bio LLC, Merck KgaA, MaxCyte Inc., Lonza Group, Bio-Rad Laboratories Inc., and Thermo Fisher Scientific Inc., among others. Thermo Fisher Scientific Inc. held the largest market share in 2021 due to its wide product portfolio and strong global distribution network.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it